Novel use of Cytosorb™ haemadsorption to provide biochemical control in liver impairment

Journal Title: Journal of the Intensive Care Society - Year 2019, Vol 20, Issue 2

Abstract

We describe the use of Cytosorb™, a synthetic extracorporeal haemoperfusion adsorption column, in the management of two patients with drug induced cholestasis and a third with alcoholic hepatitis and subsequent acute on chronic liver failure. Cytosorb was used in these patients to remove bilirubin and bile acids by supporting impaired excretory hepatic function, alleviating symptoms with the intention of serving as a bridge to endogenous recovery. The first two cases demonstrate favourable biochemical and symptomatic responses; the third case demonstrated a good biochemical response but subsequently died from the complications of multiple organ failure. These cases suggest Cytosorb™ be evaluated as an adjunct to support liver excretory functions in other arenas, such as acute liver failure or overdose. It remains unclear whether extracorporeal therapies removing liver toxins allow faster or more complete spontaneous recovery of endogenous function.

Authors and Affiliations

VD Dhokia, D Madhavan, A Austin, Craig G Morris

Keywords

Related Articles

Decision-making in intensive care: Influence of DNACPR status

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Is presumed consent an ethically acceptable way of obtaining organs for transplant?

The near-universal acceptance of cadaveric organ donation has been based on the provision of explicit consent by the donor while alive, either in the form of a formal opt-in or informal discussion of wishes with next of...

Incidence of general surgical procedures in adult patients on extracorporeal membrane oxygenation

Extracorporeal membrane oxygenation use may predispose patients to developing conditions that require either consultation with a general surgeon or a general surgical procedure. We aimed to evaluate the incidence and out...

Novel use of Cytosorb™ haemadsorption to provide biochemical control in liver impairment

We describe the use of Cytosorb™, a synthetic extracorporeal haemoperfusion adsorption column, in the management of two patients with drug induced cholestasis and a third with alcoholic hepatitis and subsequent a...

Severe meningococcal serogroup W sepsis presenting as myocarditis: A case report and review of literature

The global incidence of invasive meningococcal disease due to serogroup W (MenW) has risen over the last decade. The following case emphasises the atypical features of MenW meningococcaemia, which included myocarditis, a...

Download PDF file
  • EP ID EP679559
  • DOI  10.1177/1751143718772789
  • Views 43
  • Downloads 0

How To Cite

VD Dhokia, D Madhavan, A Austin, Craig G Morris (2019). Novel use of Cytosorb™ haemadsorption to provide biochemical control in liver impairment. Journal of the Intensive Care Society, 20(2), -. https://europub.co.uk/articles/-A-679559